An Open-Label Cohort Study to Evaluate the Safety and Pharmacokinetics of Redosing EXPAREL Via Local Subcutaneous Infiltration in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2017
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary)
- Indications Anaesthesia; Pain; Postoperative pain
- Focus Pharmacokinetics
- Sponsors Pacira Pharmaceuticals
- 25 Jan 2017 Results assessing pharmacokinetic profile and tolerability, published in the Clinical Drug Investigation.
- 25 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2014 Planned End Date changed from 1 Oct 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.